AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Activity

42 hedge funds and large institutions have $139M invested in Avadel Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 14 closing their positions.

Holders
42
Holders Change
-2
Holders Change %
-4.55%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
12
Increased
10
Reduced
8
Closed
14
Calls
$3.79M
Puts
$1.61M
Net Calls
+$2.18M
Net Calls Change
+$1.77M

Top Buyers

1
RI
1
RTW Investments
New York
$25.7M
2
ACP
2
Acuta Capital Partners
California
$12.3M
3
GJL
3
Gendell Jeffrey L
$8.66M
4
Millennium Management
4
Millennium Management
New York
$4.75M
5
IAM
5
Iridian Asset Management
Connecticut
$2.34M

Top Sellers

1
BIP
1
Brandes Investment Partners
California
$27.6M
2
BC
2
Broadfin Capital
New York
$7.77M
3
DM
3
Deerfield Management
New York
$0
4
Ameriprise
4
Ameriprise
Minnesota
$3.63M
5
JAM
5
JW Asset Management
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Northwestern Mutual Wealth Management
51
Northwestern Mutual Wealth Management
Wisconsin
– -$42K -10,000 Closed
Acadian Asset Management
52
Acadian Asset Management
Massachusetts
– -$35K -8,372 Closed
TRCT
53
Tower Research Capital (TRC)
New York
– -$3K -765 Closed
US Bancorp
54
US Bancorp
Minnesota
– -$1K -364 Closed
1 2
3